The pros and cons of the second booster dose of the COVID-19 vaccine
Abstract
No abstractNo abstractNo abstractNo abstractNo abstractNo abstract
1. UK Health Security Agency COVID-19 vaccine surveillance report: week 12. , Date: March 24, 2022, Date accessed: April 20, 2022, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1063023/Vaccine-surveillance-report-week-12.pdf
2. Pajon R, Doria-Rose NA, Shen X, Schmidt SD, O'Dell S, McDanal C, et al. SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination. N Engl J Med 2022; 386: 1088-1091.
3. Ferdinands JM, Rao S, Dixon BE, Mitchell PK, DeSilva MB, Irving SA, et al. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 states, August 2021–January 2022. MMWR Morb Mortal Wkly Rep 2022; 71: 255-263.
4. Vanshylla K, Tober-Lau P, Gruell H, Munn F, Eggeling R, Pfeifer N, et al. Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults. Lancet Infect Dis 2022; 22: 445-446.
5. European Centre for Disease Prevention and Control. COVID-19: joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines. Available from: https://www.ecdc.europa.eu/en/news-events/ema-ecdc-statement-fourth-COVID-vaccine-dose [Accessed 14 April 2022].
6. Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes second booster dose of two COVID-19 vaccines for older and immunocompromised individuals. 29 Mar 2022. https://www.fda.gov/news-events/press-announcements/coronavirus-COVID-19-update-fda-authorizes-second-booster-dose-two-COVID-19-vaccines-older-and
7. An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI): Initial guidance on a second booster dose of COVID-19 vaccines in Canada, P.A., 2022, https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/naci-guidance-second-booster-dose-covid-19-vaccines.pdf
8. Crotty S. Hybrid immunity. Science 2021; 372: 1392-1393.
9. Katelyn Jetelina, Do you need a second booster shot? An epidemiologist scoured the latest research and has some answers, https://theconversation.com/do-you-need-a-second-booster-shot-an-epidemiologist-scoured-the-latest-research-and-has-some-answers-180488
10. Bar-On YM., Sergienko R, Friger M, Peretz A, Beckenstein T, Yaron S, et al. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. N Engl J Med 2022; 386: 1712-1720.
11. Arbel R, Sergienko R, Friger M, Peretz A, Beckenstein T, Yaron S, et al. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years. Nat Med 2022; 28:1486-1490.
12. Magen O, Waxman JG, Makov-Assif M, Vered R, Dicker D, Hernan MA, et al. Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Engl J Med 2022; 386: 1603-1614.
2. Pajon R, Doria-Rose NA, Shen X, Schmidt SD, O'Dell S, McDanal C, et al. SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination. N Engl J Med 2022; 386: 1088-1091.
3. Ferdinands JM, Rao S, Dixon BE, Mitchell PK, DeSilva MB, Irving SA, et al. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 states, August 2021–January 2022. MMWR Morb Mortal Wkly Rep 2022; 71: 255-263.
4. Vanshylla K, Tober-Lau P, Gruell H, Munn F, Eggeling R, Pfeifer N, et al. Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults. Lancet Infect Dis 2022; 22: 445-446.
5. European Centre for Disease Prevention and Control. COVID-19: joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines. Available from: https://www.ecdc.europa.eu/en/news-events/ema-ecdc-statement-fourth-COVID-vaccine-dose [Accessed 14 April 2022].
6. Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes second booster dose of two COVID-19 vaccines for older and immunocompromised individuals. 29 Mar 2022. https://www.fda.gov/news-events/press-announcements/coronavirus-COVID-19-update-fda-authorizes-second-booster-dose-two-COVID-19-vaccines-older-and
7. An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI): Initial guidance on a second booster dose of COVID-19 vaccines in Canada, P.A., 2022, https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/naci-guidance-second-booster-dose-covid-19-vaccines.pdf
8. Crotty S. Hybrid immunity. Science 2021; 372: 1392-1393.
9. Katelyn Jetelina, Do you need a second booster shot? An epidemiologist scoured the latest research and has some answers, https://theconversation.com/do-you-need-a-second-booster-shot-an-epidemiologist-scoured-the-latest-research-and-has-some-answers-180488
10. Bar-On YM., Sergienko R, Friger M, Peretz A, Beckenstein T, Yaron S, et al. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. N Engl J Med 2022; 386: 1712-1720.
11. Arbel R, Sergienko R, Friger M, Peretz A, Beckenstein T, Yaron S, et al. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years. Nat Med 2022; 28:1486-1490.
12. Magen O, Waxman JG, Makov-Assif M, Vered R, Dicker D, Hernan MA, et al. Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Engl J Med 2022; 386: 1603-1614.
| Files | ||
| Issue | Vol 14 No 4 (2022) | |
| Section | Invited Commentary | |
| DOI | https://doi.org/10.18502/ijm.v14i4.10228 | |
| Keywords | ||
| Booster dose; Vaccine; COVID-19 | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Mostafavi E. The pros and cons of the second booster dose of the COVID-19 vaccine. Iran J Microbiol. 2022;14(4):435-437.
